Efficacy and Safety Evaluation of a Nutraceutical Supplement for Hair Growth, Hair Loss and Skin Improvement in Human Volunteers

Inclusion Criteria: * Women aged 50-65. * Volunteers with initial FPHL. (Images will be sent to a dermatologist for assessment). * Commitment not to use systemic, topical, or oral products with an effect similar to that of the product to be evaluated throughout the study period. * Do not change the daily routine regarding the use of cosmetic products and eating habits. * Commitment to comply with all protocol requirements specified in the subject information sheet. * Availability to comply with all study visits. Exclusion Criteria: * Women who have undergone dermatological treatment for hair loss (PRPs, mesotherapy, etc.) or hair transplant. * Scalp diseases: cicatricial alopecia, alopecia areata, folliculitis decalvans, psoriasis, moderate severe seborrheic dermatitis, eczema, cancer, etc. * Women who present alopecia because of a medical illness (hypothyroidism, anemia, lupus, etc.). * Relevant cutaneous marks in the experimental areas, which could interfere with the measurements (scars, sunburns, etc.). * In-use relevant pharmacological or hormonal treatment (eg. valproic acid, carbamazepine, phenytoin). * Women with thyroid alteration (hyper- or hypothyroidism) * Women who have previously participated in similar studies or who have used anti-hair loss products in the last 3 months. * Women who are being treated with anticoagulants, antifungals, anxiolytics, amphetamines, retinoids, iron, antithyroid, anticonvulsants, beta blockers and/or ACE inhibitors, minoxidil, finasteride, etc. * Women who started hormonal treatment (oral or topical contraceptives) in the 6 months prior to the start of the study. * Women who started taking any drug chronically less than 6 months before the start of the study (they should have a stable situation with the medication over 6 months). * Modification of the usual diet: low-calorie diet, Atkins diet, etc. * Evidence of systemic diseases (e.g. cardiac disease, psychiatric disease, etc.) or gastrointestinal diseases. * Serious conditions or illnesses that, in the opinion of the researcher, may be aggravated by participation in the study or that put the development of the study at risk. * Planned hairstyle changes throughout the study * Presence of skin diseases or melanomas. * Forecast of change of routine or relevant way of life, during the period of study. * Other exclusion criteria to be added by the investigator. * Allergy or reactivity to some of the components of the product, or a product with similar category than tested one. * Women who have gone dermatological treatment, that they have introduced minoxidil (oral or topical) at least 6 months prior, and antiandrogens (e.g. finasteride) at least 12 months before the start of the study